This CME program is derived from content presented at the 2025 Eastern Pulmonary Conference. The expert faculty, Dr. Jeffrey Hoag, will review the current clinical trial data for therapeutic options to manage non-cystic fibrosis bronchiectasis (NCFBE). Additionally, Dr. Hoag will analyze clinical strategies to apply the most appropriate therapeutic options to improve outcomes for patients with NCFBE. Dr. Hoag will also utilize a case-based format for learners to better understand how these therapeutic options apply in clinical practice. At the conclusion of this presentation, learners will gain better insight into how to treat and manage their patients with non-cystic fibrosis bronchiectasis.
Pulmonologists and other healthcare professionals involved in the treatment and management of patients with NCFBE
Review the current clinical trial data for therapeutic options to manage NCFBE
Analyze clinical strategies to apply the most appropriate therapeutic options to improve outcomes for patients with NCFBE
Case Presentation 1: Patient with Recent Onset of NCFBE and Frequent Exacerbations
Case Presentation 2: Patient with Five Year History of NCFBE and Declining Pulmonary Function
It is the policy of AcademicCME that all faculty, instructors, and planners disclose relevant financial relationships with ineligible companies. Planners have no relevant financial relationships with ineligible companies to disclose related to this activity. Faculty have disclosed the following relevant financial relationships. All relevant financial relationships have been mitigated.
| Faculty | Relationship Identified With: |
| Jeffrey Hoag, MD | Nothing to disclose |
Timothy Hayes, MD, PhD; Kim Cheramie, MSN, RN-BC, Chelsey Simonds and Nicole McMenamin hereby state that they or their spouse/life partner do not have any relevant financial relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months.
In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AcademicCME designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditsTM.
Participants should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been supported by an independent educational grant from Insmed
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and Insmed do not recommend the use of any agent outside of the labeled indications.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
In order to claim credit, participants must complete the following:
For all CE inquiries or special needs, please contact admin@academiccme.com.
811 S. Orleans Ave. Tampa, Fl 33606
